Literature DB >> 4085913

Enhancement of renal function with ornipressin in a patient with decompensated cirrhosis.

K Lenz, W Druml, G Kleinberger, H Hörtnagl, A Laggner, B Schneeweiss, E Deutsch.   

Abstract

An infusion with Ornipressin (8-ornithin vasopressin) in a patient with decompensated alcoholic liver cirrhosis increased urinary volume from 30 ml/h to 500 ml/h, creatinine clearance from 24 to 65 ml/min, and fractional sodium excretion from 0.86% to 11.1%. Free water clearance decreased from -10.2 ml/h to -26.2 ml/h and noradrenaline plasma concentrations dropped from 2.04 to 1.37 ng/ml. After stopping Ornipressin infusion all values returned to initial concentrations. Possible effects are an increase of renal blood flow secondary to an increase in arterial blood pressure, possibly potentiated by the vasodilatory effect of the fall in noradrenaline and/or angiotensin concentration.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4085913      PMCID: PMC1433121          DOI: 10.1136/gut.26.12.1385

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  4 in total

1.  The effect of octapressin on renal and intrarenal blood flow in cirrhosis of the liver.

Authors:  M C Kew; R R Varma; D J Sampson; S Sherlock
Journal:  Gut       Date:  1972-04       Impact factor: 23.059

2.  Relationship between plasma arginine vasopressin and renal water handling in decompensated cirrhosis.

Authors:  M Epstein; R E Weitzman; S Preston; A G DeNunzio
Journal:  Miner Electrolyte Metab       Date:  1984

3.  Sympathetic nervous activity and renal and systemic hemodynamics in cirrhosis: plasma norepinephrine concentration, hepatic extraction, and renal release.

Authors:  H Ring-Larsen; B Hesse; J H Henriksen; N J Christensen
Journal:  Hepatology       Date:  1982 May-Jun       Impact factor: 17.425

4.  Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis.

Authors:  D G Bichet; V J Van Putten; R W Schrier
Journal:  N Engl J Med       Date:  1982-12-16       Impact factor: 91.245

  4 in total
  3 in total

1.  Beneficial effect of 8-ornithin vasopressin on renal dysfunction in decompensated cirrhosis.

Authors:  K Lenz; H Hörtnagl; W Druml; G Grimm; A Laggner; B Schneeweisz; G Kleinberger
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

2.  Hepatorenal syndrome. Long-term treatment with terlipressin as a bridge to liver transplantation.

Authors:  N Ganne-Carrié; A Hadengue; P Mathurin; F Durand; S Erlinger; J P Benhamou
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

3.  Restricted Crystalloid Fluid Therapy during Orthotopic Liver Transplant Surgery and its Effect on Respiratory and Renal Insufficiency in the Early Post-operative Period: A Randomized Clinical Trial.

Authors:  M A Sahmeddini; F Janatmakan; M B Khosravi; S Ghaffaripour; M H Eghbal; S Nickeghbalian; S A Malek-Hosseini
Journal:  Int J Organ Transplant Med       Date:  2014
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.